Jonathan Richman (Dose of Digital) posted a blog article about “How One Pharma Company Successfully Manages YouTube” . He is refering to “ADHD: A day in the life by Janssen-Cilag Ltd”, which has been viewed 74,475 times at the time of publishing this post. Comments on this YouTube video are allowed, yet they are moderated. Drug mentions are not allowed. There are a few other comment restrictions as well. A screenshot of the commenting policy as it exists today is found below, along with a sample of some of the comments. Notice that one of the comments is from JnJ Health.
This is a great case study for Canadian pharma marketers as it seems to fit nicely within all of our Canadian regulatory guidelines. Not surprising since it it originates from the U.K., a country known for its very stringent pharma marketing guidelines.
Read Jonathan`s post (“How One Pharma Company Successfully Manages YouTube” ) for more details on this pharma YouTube video, including some comments from Gary Monk, Product Manager (Marketing) at Janssen-Cilag.
Stay in touch,
To ensure that you receive all new updates to this blog, insert your e-mail address in the box in the top-right corner. Your e-mail will remain private and will not be shared with any third parties.
Filed under: Case Study: Canadian Healthcare Social Media |